VolitionRx Limited announced that it will receive $100,000 in funding on March 12, 2024. The company will issue common shares in the transaction. The company will issue securities pursuant to exemption provided under Regulation D.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7276 USD | -2.01% | -9.05% | +1.48% |
May. 14 | Transcript : VolitionRx Limited, Q1 2024 Earnings Call, May 14, 2024 | |
May. 13 | VolitionRx Limited Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.48% | 61.5M | |
-32.63% | 9.98B | |
+23.12% | 2.87B | |
-18.33% | 2.07B | |
-24.39% | 1.59B | |
+65.65% | 1.43B | |
+32.83% | 824M | |
-6.77% | 733M | |
-29.80% | 508M | |
+0.40% | 296M |
- Stock Market
- Equities
- VNRX Stock
- News VolitionRx Limited
- VolitionRx Limited announced that it expects to receive $0.1 million in funding